Blog

Dec 9, 2024, 04:14

The 4th China-US Anti-Cancer Summit Set to Commence

Join the 4th China-US Anti-Cancer Summit

Organizer

China Anti-Cancer Association (CACA)| USCACA| World Association for Integrative Oncology (WAIO)| eChinahealth

Save the date

China Standard Time: 8:30-10:30 am, Tuesday, Dec 10th, 2024

US EST: 7:30-9:30 pm, Monday, Dec 9th, 2024

US PST: 4:30-6:30 pm, Monday, Dec 9th, 2024

Zoom Webinars | English with Chinese Simultaneous Translation

It is a great pleasure to invite you to participate in the 4th China-US Anti-Cancer Summit. This event will collaborate with leading US cancer organizations, AACR, ASCO and ACS, to offer a global platform for exploring the progress of cancer prevention and treatment. Please mark your calendars and join us via the link or QR code provided.

Opening Remark – Ying Wang

Prof. Ying Wang is Vice President of the China Anti-Cancer Association (CACA), Secretary General of the Asian Oncology Society (AOS), and Executive Associate Editor-in-Chief of Holistic Integrative Oncology (HIO). She was Deputy Director of Tianjin Medical University Cancer Institute and Hospital (1998–2014), a CACA Board Member since 1997, Secretary General of CACA (2012–2022), and became its Vice President in 2022.

Modulator – Li Yan

Prof. Li Yan is Managing Director of the US Chinese Anti-Cancer Association (USCACA) and Chief Medical Officer at Brii Biosciences. He has experience in drug development, holding leadership roles at GSK, Merck, and Johnson and Johnson, including Vice President and Global Oncology Head Unit Physician at GSK. Prof. Yan played a key role in the development and approval of several medicines, including Keytruda in China.

Speaker – Patricia LoRusso

Patricia LoRusso is Chief of Experimental Therapeutics and Associate Cancer Center Director for Experimental Therapeutics at Yale Cancer Center, where she also holds the Amy and Joseph Perella Professorship of Medicine (Medical Oncology). She is the President of the American Association for Cancer Research (AACR). An expert in medical oncology, drug development, and early-phase clinical trials, Prof. LoRusso previously served at Wayne State University’s Barbara Karmanos Cancer Institute as Director of the Phase I Clinical Trials Program and the Eisenberg Center for Experimental Therapeutics.